June 21, 2024

FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flaws

The agency’s staff analysis suggests that approval of the illegal drug known as Ecstasy for treatment of PTSD is far from certain, with advisers meeting next week to consider the proposed therapy.The agency’s staff analysis suggests that approval of the illegal drug known as Ecstasy for treatment of PTSD is far from certain, with advisers meeting next week to consider the proposed therapy.Read MorePsychedelic and Hallucinogenic Drugs, Drug Abuse and Traffic, Veterans, Post-Traumatic Stress Disorder, Mental Health and Disorders, Regulation and Deregulation of Industry, Therapy and Rehabilitation, Drugs (Pharmaceuticals), Clinical Trials, Ecstasy (Drug), Research, Depression (Mental), Placebos, Alternative and Complementary Medicine, American Psychiatric Assn, Drug Enforcement Administration, Food and Drug Administration, MAPS Public Benefit CorpNYT > Health

Leave a Reply

Your email address will not be published. Required fields are marked *